Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

SAB Biotherapeutics (SABS)

SAB Biotherapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:SABS
DateTimeSourceHeadlineSymbolCompany
06/05/202412:15GlobeNewswire Inc.SAB Biotherapeutics Appoints Jay Skyler, MD, to the Board of DirectorsNASDAQ:SABSSAB Biotherapeutics Inc
16/04/202412:15GlobeNewswire Inc.SAB Biotherapeutics Provides SAB-142 Trial UpdateNASDAQ:SABSSAB Biotherapeutics Inc
08/04/202412:15GlobeNewswire Inc.SAB Biotherapeutics to Present at INNODIA Annual MeetingNASDAQ:SABSSAB Biotherapeutics Inc
04/04/202412:15GlobeNewswire Inc.SAB Biotherapeutics to Present at the Needham Virtual Healthcare ConferenceNASDAQ:SABSSAB Biotherapeutics Inc
29/03/202411:15GlobeNewswire Inc.SAB Biotherapeutics Reports Full Year 2023 Operating and Financial ResultsNASDAQ:SABSSAB Biotherapeutics Inc
25/03/202414:15GlobeNewswire Inc.SAB Biotherapeutics Announces Clinical Partnership with Naval Medical Research Center to Advance Potential Influenza TreatmentNASDAQ:SABSSAB Biotherapeutics Inc
08/03/202421:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SABSSAB Biotherapeutics Inc
23/02/202421:55Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SABSSAB Biotherapeutics Inc
23/02/202421:45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SABSSAB Biotherapeutics Inc
23/02/202413:00GlobeNewswire Inc.SAB Biotherapeutics to Present at the BIO CEO & Investor ConferenceNASDAQ:SABSSAB Biotherapeutics Inc
08/02/202413:00GlobeNewswire Inc.SAB Biotherapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences ConferenceNASDAQ:SABSSAB Biotherapeutics Inc
02/02/202412:53Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SABSSAB Biotherapeutics Inc
02/02/202412:30GlobeNewswire Inc.SAB Biotherapeutics Announces Executive Leadership ChangeNASDAQ:SABSSAB Biotherapeutics Inc
26/01/202421:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SABSSAB Biotherapeutics Inc
26/01/202421:00Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:SABSSAB Biotherapeutics Inc
25/01/202422:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SABSSAB Biotherapeutics Inc
23/01/202422:58GlobeNewswire Inc.SAB Biotherapeutics Regains Compliance with Nasdaq Minimum Bid Price RequirementNASDAQ:SABSSAB Biotherapeutics Inc
19/01/202421:21Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SABSSAB Biotherapeutics Inc
03/01/202414:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SABSSAB Biotherapeutics Inc
02/01/202421:30GlobeNewswire Inc.SAB Biotherapeutics Announces 1-for-10 Reverse Stock SplitNASDAQ:SABSSAB Biotherapeutics Inc
18/12/202314:34Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:SABSSAB Biotherapeutics Inc
08/12/202322:26Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:SABSSAB Biotherapeutics Inc
30/11/202322:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SABSSAB Biotherapeutics Inc
29/11/202312:40Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SABSSAB Biotherapeutics Inc
29/11/202312:30GlobeNewswire Inc.SAB Biotherapeutics Announces Commencement of the HUMAN Phase 1 Clinical Trial with SAB-142, a Potential Disease-Modifying Treatment for Type 1 DiabetesNASDAQ:SABSSAB Biotherapeutics Inc
29/11/202305:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:SABSSAB Biotherapeutics Inc
28/11/202321:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SABSSAB Biotherapeutics Inc
28/11/202321:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SABSSAB Biotherapeutics Inc
22/11/202321:45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SABSSAB Biotherapeutics Inc
20/11/202322:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SABSSAB Biotherapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:SABS

Your Recent History

Delayed Upgrade Clock